Recurrent Thromboembolism in Pediatric Congenital Heart Disease: Cumulative Incidence and Prognostic Factors

Amy L Kiskaddon1,2,3,4, Therese M Giglia5, Marisol Betensky6,7

  • 1Divisions of Hematology and Cardiology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.

PubMed

Insights

Children with congenital heart disease (CHD) face a high risk of recurrent thromboembolism (TE). Immobility and central venous catheter use are key risk factors for TE recurrence in this population.

Area of Science:

  • Pediatric Cardiology
  • Thrombosis Research
  • Congenital Heart Disease

Background:

  • Congenital heart disease (CHD) is a known risk factor for thromboembolism (TE).
  • Limited data exist on the rate and risk factors for recurrent TE in pediatric patients with CHD.

Purpose of the Study:

  • To prospectively evaluate the recurrence risk of TE in children with CHD.
  • To identify clinical risk factors associated with recurrent TE in this cohort.

Main Methods:

  • Prospective inception cohort study of patients under 21 years with CHD and acute TE.
  • Data collected on CHD and thrombus characteristics, antithrombotic regimens, bleeding, and recurrent TE.
  • Multivariable logistic regression used to determine independent risk factors for recurrence.

Main Results:

  • Among 40 children, 33% experienced recurrent TE within a median of 86 days; 1-year cumulative incidence was 38%.
  • Central venous catheter (CVC)-related TE accounted for 67% of recurrent events.
  • Immobility (adjusted OR 13.2) and CVC presence (adjusted OR 5.28) were independent risk factors for recurrent TE.

Conclusions:

  • Pediatric patients with CHD and acute TE have a high risk of TE recurrence.
  • Immobility and the presence of a CVC are significant independent risk factors.
  • Further multicenter studies are needed to confirm and expand these findings.